Clik here to view.
Pharmatech and InQui Capital Team Up to Offer Development Services to Life...
HAYWARD, Calif. Pharmatech Associates and InQui Capital of Hong Kong today announced the Pharmatech Connect program, a collaboration bringing development opportunities to early stage life science...
View ArticleClik here to view.
New Study Shows Garlock’s GYLON BIO-PRO® Sanitary Gasket Meets Highest...
PALMYRA, N.Y. The Garlock family of companies is proud to announce that a new study confirmed that the GYLON BIO-PRO® sanitary gasket meets the high standards of quality and performance required for...
View ArticleClik here to view.
Takeda Announces Consolidation of U.S. Vaccine Sites in Boston/Cambridge Area
DEERFIELD, Ill. & OSAKA, Japan Takeda Pharmaceutical Company Limited (“Takeda”) will consolidate its Vaccine Business Unit (VBU) operations by establishing global and regional hubs as the...
View ArticleClik here to view.
Stroke Prevention App Paves the Way for World-First Global Study
AUCKLAND, New Zealand Internationally praised app Stroke Riskometer™ will aim to reduce the cases of stroke and several other chronic diseases such as diabetes and heart disease by collecting and...
View ArticleClik here to view.
楼氏电子推出市场上尺寸最小、能效最高且配置I2S接口的数字MEMS麦克风
伊利诺斯州伊塔斯卡 (美国商业资讯)–先进微声学解决方案和专业声学元件的市场领军企业和全球供应商楼氏电子(Knowles Corporation, NYSE: KN)今日宣布，公司已面向可穿戴设备、遥控器、汽车以及智能家居自动化和安全等领域推出最先进的Inter-IC Sound或I²S接口的MEMS（微机电系统）麦克风。...
View ArticleClik here to view.
Hanmi Pharmaceutical to Present Its New Diabetes Drugs Including Quantum...
SEOUL, South Korea Hanmi Pharmaceutical Co., Ltd.(KSE: 128940) will present its 11 studies on 4 new drugs including the results of the phase IIb clinical trial of ‘efpeglenatide’ at the American...
View ArticleClik here to view.
Latest Brainlab software for treatment of brain metastases and benign skull...
YOKOHAMA, Japan Experts in stereotactic radiosurgery (SRS) from all over the globe will be presenting Brainlab software innovations at this year’s International Stereotactic Radiosurgery Society...
View ArticleClik here to view.
Trophogen, Inc.宣布与Zoetis, Inc.就用于牛排卵过度的重组长效和超级活性牛卵泡刺激素(rbFSH)拟似物签订排他性全球兽药授权和采购协议
马里兰州罗克维尔 (美国商业资讯) — Trophogen, Inc.今天宣布，该公司与领先的全球性动物健康公司Zoetis, Inc. 签订了一份授权和采购协议，后者获得排他性授权，以开发Trophogen的重组修饰的牛卵泡刺激素(rbFSH)拟似物，用于动物健康繁殖领域。根据协议条款，该重组长效牛FSH超级激动剂拟似物用于肉牛和乳牛的排卵过度和胚胎转移的可能性将得到评估和开发。...
View ArticleClik here to view.
エリテックがASCOでGRASPA®の第III相（ALL）の完全な結果を報告し、第IIb相（AML）の最新情報を提供
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック（Paris:ERYP）（ADR:EYRYY）（Euronext Paris – ERYP; OTC US –...
View ArticleClik here to view.
Clik here to view.
World Glaucoma Congress to Feature Symposium on XEN Gel Stent for Minimally...
ALISO VIEJO, Calif. AqueSys, Inc., the developer of minimally invasive stent technology for the treatment of glaucoma, announced today it will host a XEN Gel Stent Symposium at the 6th Annual World...
View ArticleClik here to view.
Guided Therapeutics Awarded Multiple Tenders for LuViva® Advanced Cervical...
DHAKA, Bangladesh Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) announced today that its distributor in Bangladesh has been awarded contracts for four additional LuViva® Advanced Cervical...
View ArticleClik here to view.
Clik here to view.
Hanmi Pharmaceutical : Once-Weekly Insulin Combination, ‘LAPSInsulin Combo’,...
SEOUL, South Korea Hanmi Pharmaceutical Co., Ltd.(KSE: 128940) made an oral presentation on the non-clinical results of once weekly insulin and GLP-1 combination drug ‘LAPSInsulin Combo’ at the 75th...
View ArticleClik here to view.
R-Tech Ueno: Announcement on Collaborative Development of Therapeutic Agent...
TOKYO R-Tech Ueno (JASDAQ: 4573) R-Tech Ueno, Ltd. has announced plans to conduct collaborative research with Autonomous University of Barcelona (UAB) and Vall d’Hebron Institute of Research (VHIR),...
View ArticleClik here to view.
New Data Presented at ADA Demonstrate Early Effect of EndoBarrier Therapy on...
LEXINGTON, Mass. & SYDNEY GI Dynamics, Inc. (ASX: GID), a medical device company, provides innovative treatments for type 2 diabetes and obesity, today announced new data showing the effect of...
View ArticleClik here to view.
CEL-SCI is Cleared to Start Patient Enrollment for Its Phase 3 Cancer...
VIENNA, Va. CEL-SCI Corporation (NYSE MKT: CVM) (“CEL SCI” or the “Company”) today announced that CEL-SCI is now cleared to start patient enrollment in Thailand in its ongoing Phase 3 trial with its...
View ArticleClik here to view.
Hanmi Pharmaceutical: Efpeglenatide (GLP-1 Analog), the Promising Potential...
SEOUL, South Korea Hanmi Pharmaceutical Co., Ltd.(KSE: 128940) announced that they presented 5 clinical and non-clinical studies with ‘efpeglenatide (LAPSCA-Exendin-4)’ at the 75th ADA Scientific...
View ArticleClik here to view.
Allele Biotechnology & Pharmaceuticals Closes Purchase of cGMP Facility for...
SAN DIEGO Allele Biotechnology & Pharmaceuticals, Inc. (“Allele”), a leader in the development of specialized cells for pharmaceutical drug discovery and regenerative medicine, today announced...
View ArticleClik here to view.
Allele Biotechnology & Pharmaceuticals完成对cGMP设施的收购，用于生产面向细胞疗法应用的临床级细胞
圣迭戈 (美国商业资讯) — Allele Biotechnology & Pharmaceuticals, Inc. (“Allele”)是开发面向药品发现和再生医学的专用细胞的领先者，该公司今天宣布已完成对一处新设施的收购，用于其按现行药品生产质量管理规范(cGMP)生产面向细胞疗法应用的临床级细胞。...
View Article